Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$214.88 - $256.94 $305,989 - $365,882
1,424 New
1,424 $313,000
Q1 2023

May 05, 2023

BUY
$212.99 - $276.17 $216,823 - $281,141
1,018 New
1,018 $227,000
Q2 2022

Aug 05, 2022

SELL
$174.81 - $241.14 $247,705 - $341,695
-1,417 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$166.16 - $213.96 $235,448 - $303,181
1,417 New
1,417 $254,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mqs Management LLC Portfolio

Follow Mqs Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.